References

Key articles

Hogberg L, Falth-Magnusson K, Grodzinsky E, et al. Familial prevalence of coeliac disease: a twenty-year follow-up study. Scand J Gastroenterol. 2003 Jan;38(1):61-5.

van der Windt DA, Jellema P, Mulder CJ, et al. Diagnostic testing for celiac disease among patients with abdominal symptoms: a systematic review. JAMA. 2010 May 5;303(17):1738-46.

Husby S, Koletzko S, Korponay-Szabó IR, et al; ESPGHAN Working Group on Coeliac Disease Diagnosis; ESPGHAN Gastroenterology Committee; European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr. 2012 Jan;54(1):136-60.

National Institute for Health and Care Excellence. Coeliac disease: recognition, assessment and management. September 2015 [internet publication].

Vriezinga SL, Auricchio R, Bravi E, et al. Randomized feeding intervention in infants at high risk for celiac disease. N Engl J Med. 2014 Oct 2;371(14):1304-15.

Lionetti E, Castellaneta S, Francavilla R, et al. Introduction of gluten, HLA status, and the risk of celiac disease in children. N Engl J Med. 2014 Oct 2;371(14):1295-303.

Hogberg L, Laurin P, Falth-Magnusson K, et al. Oats to children with newly diagnosed coeliac disease: a randomised double blind study. Gut. 2004 May;53(5):649-54.

Academy of Nutrition and Dietetics (American Dietetic Association). Celiac disease evidence-based nutrition practice guideline. May 2009. http://www.andevidencelibrary.com (last accessed 5 June 2017).

West J, Logan RF, Smith CJ, et al. Malignancy and mortality in people with coeliac disease: population based cohort study. BMJ. 2004 Sep 25;329(7468):716-9.

Reference articles

1. Singh P, Arora A, Strand TA, et al. Global prevalence of celiac disease: systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2018 Jun;16(6):823-36.

2. Sood A, Midha V, Sood N, et al. Prevalence of celiac disease among school children in Punjab, North India. J Gastroenterol Hepatol. 2006 Oct;21(10):1622-5.

3. Ertekin V, Selimoglu MA, Kardas F, et al. Prevalence of celiac disease in Turkish children. J Clin Gastroenterol. 2005 Sep;39(8):689-91.

4. Yap TW, Chan WK, Leow AH, et al. Prevalence of serum celiac antibodies in a multiracial Asian population: a first study in the young Asian adult population of Malaysia. PLoS One. 2015 Mar 23;10(3):e0121908.

5. Cummins AG, Roberts-Thomson IC. Prevalence of celiac disease in the Asia-Pacific region. J Gastroenterol Hepatol. 2009 Aug;24(8):1347-51.

6. Choung RS, Unalp-Arida A, Ruhl CE, et al. Less hidden celiac disease but increased gluten avoidance without a diagnosis in the United States: findings from the National Health and Nutrition Examination Surveys from 2009 to 2014. Mayo Clin Proc. 2016 Dec 5 [Epub ahead of print].

7. Green PH. The many faces of celiac disease: clinical presentation of celiac disease in the adult population. Gastroenterology. 2005 Apr;128(4 Suppl 1):S74-8.

8. Green PH, Stavropoulos SN, Panagi SG, et al. Characteristics of adult celiac disease in the USA: results of a national survey. Am J Gastroenterol. 2001 Jan;96(1):126-31.

9. Bouziat R, Hinterleitner R, Brown JJ, et al. Reovirus infection triggers inflammatory responses to dietary antigens and development of celiac disease. Science. 2017 Apr 7;356(6333):44-50.

10. Shan L, Molberg Ø, Parrot I, et al. Structural basis for gluten intolerance in celiac sprue. Science. 2002 Sep 27;297(5590):2275-9.

11. Ráki M, Tollefsen S, Molberg Ø, et al. A unique dendritic cell subset accumulates in the celiac lesion and efficiently activates gluten-reactive T cells. Gastroenterology. 2006 Aug;131(2):428-38.

12. Mention JJ, Ben Ahmed M, Bègue B, et al. Interleukin 15: a key to disrupted intraepithelial lymphocyte homeostasis and lymphomagenesis in celiac disease. Gastroenterology. 2003 Sep;125(3):730-45.

13. Abadie V, Jabri B. IL-15: a central regulator of celiac disease immunopathology. Immunol Rev. 2014 Jul;260(1):221-34.

14. Di Sabatino A, Ciccocioppo R, Cupelli F, et al. Epithelium derived interleukin 15 regulates intraepithelial lymphocyte Th1 cytokine production, cytotoxicity, and survival in coeliac disease. Gut. 2006 Apr;55(4):469-77.

15. Dieterich W, Ehnis T, Bauer M, et al. Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med. 1997 Jul;3(7):797-801.

16. Dieterich W, Esslinger B, Schuppan D. Pathomechanisms in celiac disease. Int Arch Allergy Immunol. 2003 Oct;132(2):98-108.

17. Hogberg L, Falth-Magnusson K, Grodzinsky E, et al. Familial prevalence of coeliac disease: a twenty-year follow-up study. Scand J Gastroenterol. 2003 Jan;38(1):61-5.

18. Collin P, Maki M, Keyrilainen O, et al. Selective IgA deficiency and coeliac disease. Scand J Gastroenterol. 1992 May;27(5):367-71.

19. Smyth DJ, Plagnol V, Walker NM, et al. Shared and distinct genetic variants in type 1 diabetes and celiac disease. N Engl J Med. 2008 Dec 25;359(26):2767-77.

20. Kozhakhmetova A, Wyatt RC, Caygill C, et al. A quarter of patients with type 1 diabetes have co-existing non-islet autoimmunity: the findings of a UK population-based family study. Clin Exp Immunol. 2018 Jun;192(3):251-8.

21. Barera G, Bonfanti R, Viscardi M, et al. Occurrence of celiac disease after onset of type 1 diabetes: a 6-year prospective longitudinal study. Pediatrics. 2002 May;109(5):833-8.

22. Vaarala O, Atkinson MA, Neu J. The "perfect storm" for type 1 diabetes: the complex interplay between intestinal microbiota, gut permeability, and mucosal immunity. Diabetes. 2008 Oct;57(10):2555-62.

23. Elfström P, Montgomery SM, Kämpe O, et al. Risk of thyroid disease in individuals with celiac disease. J Clin Endocrinol Metab. 2008 Oct;93(10):3915-21.

24. Roy A, Laszkowska M, Sundström J, et al. Prevalence of celiac disease in patients with autoimmune thyroid disease: a meta-analysis. Thyroid. 2016 Jul;26(7):880-90.

25. Book L, Hart A, Black J, et al. Prevalence and clinical characteristics of celiac disease in Downs syndrome in a US study. Am J Med Genet. 2001 Jan 1;98(1):70-4.

26. Alanay Y, Boduroglu K, Tuncbilek E. Celiac disease screening in 100 Turkish children with Down syndrome. Turk J Pediatr. 2005 Apr-Jun;47(2):138-40.

27. Szodoray P, Barta Z, Lakos G, et al. Coeliac disease in Sjogren's syndrome: a study of 111 Hungarian patients. Rheumatol Int. 2004 Sep;24(5):278-82.

28. Yang A, Chen Y, Scherl E, et al. Inflammatory bowel disease in patients with celiac disease. Inflamm Bowel Dis. 2005 Jun;11(6):528-32.

29. Bizzaro N, Villalta D, Tonutti E, et al. IgA and IgG tissue transglutaminase antibody prevalence and clinical significance in connective tissue diseases, inflammatory bowel disease, and primary biliary cirrhosis. Dig Dis Sci. 2003 Dec;48(12):2360-5.

30. Ford AC, Ching E, Moayyedi P. Meta-analysis: yield of diagnostic tests for coeliac disease in dyspepsia. Aliment Pharmacol Ther. 2009 Jul;30(1):28-36.

31. Ford AC, Chey WD, Talley NJ, et al. Yield of diagnostic tests for celiac disease in individuals with symptoms suggestive of irritable bowel syndrome: systematic review and meta-analysis. Arch Intern Med. 2009 Apr 13;169(7):651-8.

32. Irvine AJ, Chey WD, Ford AC. Screening for celiac disease in irritable bowel syndrome: an updated systematic review and meta-analysis. Am J Gastroenterol. 2017 Jan;112(1):65-76.

33. Pastore L, Carroccio A, Compilato D, et al. Oral manifestations of celiac disease. J Clin Gastroenterol. 2008 Mar;42(3):224-32.

34. van der Windt DA, Jellema P, Mulder CJ, et al. Diagnostic testing for celiac disease among patients with abdominal symptoms: a systematic review. JAMA. 2010 May 5;303(17):1738-46.

35. Lewis NR, Scott BB. Meta-analysis: deamidated gliadin peptide antibody and tissue transglutaminase antibody compared as screening tests for coeliac disease. Aliment Pharmacol Ther. 2010 Jan;31(1):73-81.

36. Lewis NR, Scott BB. Systematic review: the use of serology to exclude or diagnose coeliac disease (a comparison of the endomysial and tissue transglutaminase antibody tests). Aliment Pharmacol Ther. 2006 Jul 1;24(1):47-54.

37. Volta U, Fabbri A, Parisi C, et al. Old and new serological tests for celiac disease screening. Expert Rev Gastroenterol Hepatol. 2010 Feb;4(1):31-5.

38. Husby S, Koletzko S, Korponay-Szabó IR, et al; ESPGHAN Working Group on Coeliac Disease Diagnosis; ESPGHAN Gastroenterology Committee; European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr. 2012 Jan;54(1):136-60.

39. Marsh MN. The immunopathology of small intestinal reaction in gluten-sensitivity. Immunol Invest. 1989 Jan-May;18(1-4):509-31.

40. Leffler DA, Schuppan D, Pallav K, et al. Kinetics of the histological, serological and symptomatic responses to gluten challenge in adults with coeliac disease. Gut. 2013 Jul;62(7):996-1004.

41. National Institute for Health and Care Excellence. Coeliac disease: recognition, assessment and management. September 2015 [internet publication].

42. Farrell RJ, Kelly CP. Celiac sprue. N Engl J Med. 2002 Jan 17;346(3):180-8.

43. Rubio-Tapia A, Hill ID, Kelly CP, et al. ACG clinical guidelines: diagnosis and management of celiac disease. Am J Gastroenterol. 2013 May;108(5):656-76.

44. DeMelo EN, McDonald C, Saibil F, et al. Celiac disease and type 1 diabetes in adults: is this a high-risk group for screening? Can J Diabetes. 2015 Dec;39(6):513-9.

45. Skelin M, Lucijanić T, Amidžić Klarić D, et al. Factors affecting gastrointestinal absorption of levothyroxine: a review. Clin Ther. 2017 Feb;39(2):378-403.

46. Kyriacou A, McLaughlin J, Syed AA. Thyroid disorders and gastrointestinal and liver dysfunction: a state of the art review. Eur J Intern Med. 2015 Oct;26(8):563-71.

47. Sun X, Lu L, Yang R, et al. Increased incidence of thyroid disease in patients with celiac disease: a systematic review and meta-analysis. PLoS One. 2016 Dec 28;11(12):e0168708.

48. Hill ID, Dirks MH, Liptak GS, et al. Guideline for the diagnosis and treatment of celiac disease in children: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr. 2005 Jan;40(1):1-19.

49. Chand N, Mihas AA. Celiac disease: current concepts in diagnosis and treatment. J Clin Gastroenterol. 2006 Jan;40(1):3-14.

50. Jeffers MD, Hourihane DO. Coeliac disease with histological features of peptic duodenitis: value of assessment of intraepithelial lymphocytes. J Clin Pathol. 1993 May;46(5):420-4.

51. Centers for Disease Control and Prevention. Parasites: giardia. July 2015 [internet publication].

52. Quigley EM, Quera R. Small intestinal bacterial overgrowth: roles of antibiotics, prebiotics, and probiotics. Gastroenterology. 2006 Feb;130(2 Suppl 1):S78-90.

53. Singh VV, Toskes PP. Small bowel bacterial overgrowth: presentation, diagnosis and treatment. Curr Treat Options Gastroenterol. 2004 Feb;7(1):19-28.

54. Sood M, Booth IW. Is prolonged rotavirus infection a common cause of protracted diarrhoea? Arch Dis Child. 1999 Apr;80(4):309-10.

55. Biswas S, Hoo W, Katsoulas N, et al. Eosinophilic enteritis: a rare cause of abdominal pain. Int J Colorectal Dis. 2007 Jan;22(1):87-8.

56. Westergaard H. Tropical sprue. Curr Treat Options Gastroenterol. 2004 Feb;7(1):7-11.

57. Prakash C, Levin MS. Diagnosis and management of small intestinal diseases. Curr Opin Gastroenterol. 1999 Mar;15(2):132-40.

58. Corazza GR, Biagi F, Volta U, et al. Autoimmune enteropathy and villous atrophy in adults. Lancet. 1997 Jul 12;350(9071):106-9.

59. Basson M, Mezzarobba M, Weill A, et al. Severe intestinal malabsorption associated with olmesartan: a French nationwide observational cohort study. Gut. 2016 Oct;65(10):1664-9.

60. Marietta EV, Cartee A, Rishi A, et al. Drug-induced enteropathy. Dig Dis. 2015;33(2):215-20.

61. Vriezinga SL, Auricchio R, Bravi E, et al. Randomized feeding intervention in infants at high risk for celiac disease. N Engl J Med. 2014 Oct 2;371(14):1304-15.

62. Lionetti E, Castellaneta S, Francavilla R, et al. Introduction of gluten, HLA status, and the risk of celiac disease in children. N Engl J Med. 2014 Oct 2;371(14):1295-303.

63. Pinto-Sánchez MI, Verdu EF, Liu E, et al. Gluten introduction to infant feeding and risk of celiac disease: systematic review and meta-analysis. J Pediatr. 2016 Jan;168:132-43.

64. Enns RA, Hookey L, Armstrong D, et al. Clinical practice guidelines for the use of video capsule endoscopy. Gastroenterology. 2017 Feb;152(3):497-514.

65. US Preventive Services Task Force. Celiac disease: screening. March 2017 [internet publication].

66. World Gastroenterology Organisation. WGO practice guideline: celiac disease. July 2016 [internet publication].

67. Fasano A, Araya M, Bhatnagar S, et al; Celiac Disease Working Group, FISPGHAN. Federation of International Societies of Pediatric Gastroenterology, Hepatology, and Nutrition consensus report on celiac disease. J Pediatr Gastroenterol Nutr. 2008 Aug;47(2):214-9.

68. Pennazio M, Spada C, Eliakim R, et al. Small-bowel capsule endoscopy and device-assisted enteroscopy for diagnosis and treatment of small-bowel disorders: European Society of Gastrointestinal Endoscopy (ESGE) clinical guideline. Endoscopy. 2015 Apr;47(4):352-76.

69. Vici G, Belli L, Biondi M, et al. Gluten free diet and nutrient deficiencies: a review. Clin Nutr. 2016 Dec;35(6):1236-41.

70. Bascuñán KA, Vespa MC, Araya M. Celiac disease: understanding the gluten-free diet. Eur J Nutr. 2017 Mar;56(2):449-59.

71. Burger JPW, de Brouwer B, IntHout J, et al. Systematic review with meta-analysis: dietary adherence influences normalization of health-related quality of life in coeliac disease. Clin Nutr. 2017 Apr;36(2):399-406.

72. Hall NJ, Rubin G, Charnock A. Systematic review: adherence to a gluten-free diet in adult patients with coeliac disease. Aliment Pharmacol Ther. 2009 Aug 15;30(4):315-30.

73. Leffler DA, Kelly CP, Green PH, et al. Larazotide acetate for persistent symptoms of celiac disease despite a gluten-free diet: a randomized controlled trial. Gastroenterology. 2015 Jun;148(7):1311-9.

74. Losurdo G, Marra A, Shahini E, et al. Small intestinal bacterial overgrowth and celiac disease: a systematic review with pooled-data analysis. Neurogastroenterol Motil. 2017 Jun;29(6):13028.

75. Cellier C, Delabesse E, Helmer C, et al. Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphoma. Lancet. 2000 Jul 15;356(9225):203-8.

76. Holm K, Maki M, Vuolteenaho N, et al. Oats in the treatment of childhood coeliac disease: a 2-year controlled trial and a long-term clinical follow-up study. Aliment Pharmacol Ther. 2006 May 15;23(10):1463-72.

77. Hogberg L, Laurin P, Falth-Magnusson K, et al. Oats to children with newly diagnosed coeliac disease: a randomised double blind study. Gut. 2004 May;53(5):649-54.

78. Garsed K, Scott BB. Can oats be taken in a gluten-free diet? A systematic review. Scand J Gastroenterol. 2007 Feb;42(2):171-8.

79. Murray JA, Kelly CP, Green PHR, et al. No difference between latiglutenase and placebo in reducing villous atrophy or improving symptoms in patients with symptomatic celiac disease. Gastroenterology. 2017 Mar;152(4):787-98.

80. Syage JA, Murray JA, Green PHR, et al. Latiglutenase improves symptoms in seropositive celiac disease patients while on a gluten-free diet. Dig Dis Sci. 2017 Sep;62(9):2428-32.

81. Leffler DA, Kelly CP, Abdallah HZ, et al. A randomized, double-blind study of larazotide acetate to prevent the activation of celiac disease during gluten challenge. Am J Gastroenterol. 2012 Oct;107(10):1554-62.

82. Benahmed M, Mention JJ, Matysiak-Budnik T, et al. Celiac disease: a future without gluten-free diet? Gastroenterology. 2003 Oct;125(4):1264-7.

83. Goel G, King T, Daveson AJ, et al. Epitope-specific immunotherapy targeting CD4-positive T cells in coeliac disease: two randomised, double-blind, placebo-controlled phase 1 studies. Lancet Gastroenterol Hepatol. 2017 Jul;2(7):479-93.

84. ClinicalTrials.gov. Study of the safety, tolerability and pharmacokinetics of TIMP-GLIA in subjects with celiac disease. April 2018 [internet publication].

85. ClinicalTrials.gov. Study to evaluate the efficacy and safety of AMG 714 in adult patients with type ii refractory celiac disease. February 2018 [internet publication].

86. Smecuol E, Hwang HJ, Sugai E, et al. Exploratory, randomized, double-blind, placebo-controlled study on the effects of Bifidobacterium infantis natren life start strain super strain in active celiac disease. J Clin Gastroenterol. 2013 Feb;47(2):139-47.

87. Caminero A, Galipeau HJ, McCarville JL, et al. Duodenal bacteria from patients with celiac disease and healthy subjects distinctly affect gluten breakdown and immunogenicity. Gastroenterology. 2016 Oct;151(4):670-83.

88. Sánchez-León S, Gil-Humanes J, Ozuna CV, et al. Low-gluten, nontransgenic wheat engineered with CRISPR/Cas9. Plant Biotechnol J. 2018 Apr;16(4):902-10.

89. Costabile A, Bergillos-Meca T, Landriscina L, et al. An in vitro fermentation study on the effects of Gluten Friendly™ bread on microbiota and short chain fatty acids of fecal samples from healthy and celiac subjects. Front Microbiol. 2017 Sep 7;8:1722.

90. Mandile R, Picascia S, Parrella C, et al. Lack of immunogenicity of hydrolysed wheat flour in patients with coeliac disease after a short-term oral challenge. Aliment Pharmacol Ther. 2017 Aug;46(4):440-6.

91. Marino M, Casale R, Borghini R, et al. The effects of modified versus unmodified wheat gluten administration in patients with celiac disease. Int Immunopharmacol. 2017 Jun;47:1-8.

92. Kupfer S, Mayassi T, Setia N, et al. Su1166: a randomized, placebo-controlled pilot study of montelukast in celiac disease. Gastroenterology. 2018 May;154(6):S-491.

    93. Academy of Nutrition and Dietetics (American Dietetic Association). Celiac disease evidence-based nutrition practice guideline. May 2009. http://www.andevidencelibrary.com (last accessed 5 June 2017).

    94. Ludvigsson JF, Agreus L, Ciacci C, et al. Transition from childhood to adulthood in coeliac disease: the Prague consensus report. Gut. 2016;65:1242-1251.

    95. Haines ML, Anderson RP, Gibson PR. Systematic review: the evidence base for long-term management of coeliac disease. Aliment Pharmacol Ther. 2008 Nov 1;28(9):1042-66.

    96. Leffler DA, Dennis M, Hyett B, et al. Etiologies and predictors of diagnosis in nonresponsive celiac disease. Clin Gastroenterol Hepatol. 2007 Apr;5(4):445-50.

    97. Askling J, Linet M, Gridley G, et al. Cancer incidence in a population-based cohort of individuals hospitalized with celiac disease or dermatitis herpetiformis. Gastroenterology. 2002 Nov;123(5):1428-35.

    98. West J, Logan RF, Smith CJ, et al. Malignancy and mortality in people with coeliac disease: population based cohort study. BMJ. 2004 Sep 25;329(7468):716-9.

    99. Green PH, Fleischauer AT, Bhagat G, et al. Risk of malignancy in patients with celiac disease. Am J Med. 2003 Aug 15;115(3):191-5.

    100. West J, Logan RF, Card TR, et al. Fracture risk in people with celiac disease: a population-based cohort study. Gastroenterology. 2003 Aug;125(2):429-36.

    101. Bai JC, Gonzalez D, Mautalen C, et al. Long-term effect of gluten restriction on bone mineral density of patients with coeliac disease. Aliment Pharmacol Ther. 1997 Feb;11(1):157-64.

    102. Scott EM, Gaywood I, Scott BB; British Society of Gastroenterology. Guidelines for osteoporosis in coeliac disease and inflammatory bowel disease. Gut. 2000 Jan;46 (Suppl 1):i1-8.

    103. Ludvigsson JF, Bai JC, Biagi F, et al. Diagnosis and management of adult coeliac disease: guidelines from the British Society of Gastroenterology. Gut. 2014 Aug;63(8):1210-28.

    104. Bai JC, Ciacci C. World Gastroenterology Organisation global guidelines: celiac disease February 2017. J Clin Gastroenterol. 2017 Oct;51(9):755-68.

    105. Simons M, Scott-Sheldon LAJ, Risech-Neyman Y, et al. Celiac disease and increased risk of pneumococcal infection: a systematic review and meta-analysis. Am J Med. 2018 Jan;131(1):83-9.

    106. Mangione RA, Patel PN. Caring for patients with celiac disease: the role of the pharmacist. J Am Pharm Assoc (2003). 2008 Sep-Oct;48(5):e125-35.

    107. Silvester JA, Kurada S, Szwajcer A, et al. Tests for serum transglutaminase and endomysial antibodies do not detect most patients with celiac disease and persistent villous atrophy on gluten-free diets: a meta-analysis. Gastroenterology. 2017 Sep;153(3):689-701.

    108. Szakács Z, Mátrai P, Hegyi P, et al. Younger age at diagnosis predisposes to mucosal recovery in celiac disease on a gluten-free diet: a meta-analysis. PLoS One. 2017 Nov 2;12(11):e0187526.

    109. Mahadev S, Murray JA, Wu TT, et al. Factors associated with villus atrophy in symptomatic coeliac disease patients on a gluten-free diet. Aliment Pharmacol Ther. 2017 Apr;45(8):1084-93.

    110. Kemppainen KM, Lynch KF, Liu E, et al. Factors that increase risk of celiac disease autoimmunity after a gastrointestinal infection in early life. Clin Gastroenterol Hepatol. 2017 May;15(5):694-702.

    Use of this content is subject to our disclaimer